US Edition

Innovaccer has crossed $200 million in annual recurring revenue, up 54% from roughly $130 million the prior year, as its agentic AI platform gains traction across seven of the top ten U.S. health systems. CEO Abhinav Shashank has set $400-500 million ARR as the IPO threshold, with the company backed by $675 million in total funding at a $3.45 billion valuation. The growth is real, but doubling revenue again in healthcare's notoriously slow enterprise market is the test that remains.